Ocular Drug Delivery market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Ocular Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Ocular Drug Delivery market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
